Cas:223382-00-1 3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride manufacturer & supplier

Chemical Name:3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride

CAS.NO:223382-00-1

Synonyms:3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride

Molecular Formula:C₁₄H₂₄Cl₃N₃

Molecular Weight:340.71900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:18.51000

Exact Mass:339.10400

LogP:3.82650

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride Use and application,3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride technical grade,usp/ep/jp grade.

Related News: In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride manufacturer In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride supplier The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG��s pharmaceutical business within the Corden Pharma platform. The companies�� goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed. 3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 3-[4-(4-Tolyl)piperazinyl]azetidine trihydrochloride factory Government officials say that the number of visitors from the mainland and other countries has decreased significantly after they closed several border points and rail stations and cut flight arrivals by half.